PED/PEA-15 interacts with the 67 kD laminin receptor and regulates cell adhesion, migration, proliferation and apoptosis

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 7, 2012, Pages 1435-1446

  Formisano, Pietro ^a   Ragno, Pia ^b   Pesapane, Ada ^a   Alfano, Daniela ^b   Alberobello, Anna Teresa ^a   Rea, Vincenza Elena Anna ^a   Giusto, Raffaella ^a   Rossi, Francesca W ^a   Beguinot, Francesco ^a   Rossi, Guido ^a   Montuori, Nunzia ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

67 laminin receptor; Adhesion; Apoptosis; PED PEA 15

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; LAMININ; LAMININ RECEPTOR; PEA15 PROTEIN, HUMAN; PHOSPHOPROTEIN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; ASTROCYTE; CELL ADHESION; CELL MOTION; CELL PROLIFERATION; CELL STRAIN HEK293; CELL SURVIVAL; DRUG EFFECT; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; GLIOBLASTOMA; HUMAN; IMMUNOPRECIPITATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; WESTERN BLOTTING;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; ASTROCYTES; BLOTTING, WESTERN; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LAMININ; PHOSPHOPROTEINS; PHOSPHORYLATION; RECEPTORS, LAMININ; TRANSFECTION;

EID: 84863092269     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01411.x     Document Type: Article

References (56)

1. Fiory F, Formisano P, Perruolo G, et al. Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism. Am J Physiol Endocrinol Metab. 2009; 297: E592-601.
2. Condorelli G, Vigliotta G, Cafieri A, et al. PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 1999; 18: 4409-15.
3. Kitsberg D, Formstecher E, Fauquet M, et al. Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci. 1999; 19: 8244-51.
4. Formstecher E, Ramos JW, Fauquet M, et al. PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell 2001; 1: 239-50.
5. Callaway K, Abramczyk O, Martin L, et al. The anti-apoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site. Biochemistry 2007; 46: 9187-98.
6. Renganathan H, Vaidyanathan H, Knapinska A, et al. Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J. 2005; 390: 729-35.
7. Kubes M, Cordier J, Glowinski J, et al. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II in vitro. J Neurochem. 1998; 71: 1307-14.
8. Trencia A, Perfetti A, Cassese A, et al. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol. 2003; 23: 4511-21.
9. Formisano P, Perruolo G, Libertini S, et al. Raised expression of the antiapoptotic protein ped/pea-15 increases susceptibility to chemically induced skin tumour development. Oncogene 2005; 24: 7012-21.
10. Zanca C, Garofalo M, Quintavalle C, et al. PED is overexpressed and mediates TRAIL resistance in human non-small cell lung cancer. J Cell Mol Med. 2008; 12: 2416-26.
11. Garofalo M, Romano G, Quintavalle C, et al. Selective inhibition of PED protein expression sensitizes B-cell chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. Int J Cancer. 2007; 120: 1215-22.
12. Todaro M, Zerilli M, Ricci-Vitiani L, et al. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res. 2006; 66: 1491-9.
13. Hao C, Beguinot F, Condorelli G, et al. Induction and intracellular regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 2001; 61: 1162-70.
14. Eckert A, Böck BC, Tagscherer KE, et al. The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene 2008; 27: 1155-66.
15. Chou FL, Hill JM, Hsieh JC, et al. PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J Biol Chem. 2003; 278: 52587-97.
16. Renault-Mihara F, Beuvon F, Iturrioz X, et al. Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism. Mol Biol Cell. 2006; 17: 5141-52.
17. Zanca C, Cozzolino F, Quintavalle C, et al. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells. J Cell Physiol. 2010; 225: 63-72.
18. Rao NC, Barsky SH, Terranova VP, et al. Isolation of a tumour cell laminin receptor. Biochem Biophys Res Commun. 1983; 111: 804-8.
19. Mecham RP. Receptors for laminin on mammalian cells. FASEB J. 1991; 5: 2538-46.
20. Graf J, Ogle RC, Robey FA, et al. A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the 67, 000 laminin receptor. Biochemistry 1987; 26: 6896-900.
21. Taraboletti G, Belotti D, Giavazzi R, et al. Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. J Natl Cancer Inst. 1993; 85: 235-40.
22. Rao CN, Castronovo V, Schmitt MC, et al. Evidence for a precursor of the high-affinity metastasis-associated murine laminin receptor. Biochemistry 1989; 28: 7476-86.
23. Landowski TH, Dratz EA, Starkey JR. Studies of the structure of the metastasis-associated 67 kDa laminin binding protein: fatty acid acylation and evidence supporting dimerization of the 32 kD gene product to form the mature protein. Biochemistry 1995; 34: 11276-87.
24. Castronovo V, Taraboletti G, Sobel ME. Functional domains of the 67 kDa laminin receptor precursor. J Biol Chem. 1991; 266: 20440-6.
25. Kazmin DA, Hoyt TR, Taubner L, et al. Phage display mapping for peptide 11 sensitive sequences binding to laminin-1. J Mol Biol. 2000; 298: 431-45.
26. Magnifico A, Tagliabue E, Butò S. Peptide G, containing the binding site of the 67 kDa laminin receptor, increases and stabilizes laminin binding to cancer cells. J Biol Chem. 1996; 271: 31179-84.
27. Ardini E, Sporchia B, Pollegioni L, et al. Identification of a novel function for 67-kDa laminin receptor: increase in laminin degradation rate and release of motility fragments. Cancer Res 2002; 62: 1321-5.
28. Berno V, Porrini D, Castiglioni F, et al. The 67 kDa laminin receptor increases tumour aggressiveness by remodeling laminin-1. Endocr Relat Cancer 2005; 12: 393-406.
29. Ardini E, Tagliabue E, Magnifico A, et al. Co-regulation and physical association of the 67 kD monomeric laminin receptor and the α6β4 integrin. J Biol Chem. 1997; 272: 2342-5.
30. Montuori N, Sobel ME. The 67-kDa laminin receptor and tumour progression. Curr Top Microbiol Immunol. 1996; 213: 205-14.
31. Wewer UM, Taraboletti G, Sobel ME, et al. Role of laminin receptor in tumour cell migration. Cancer Res. 1987; 47: 5691-8.
32. Menard S, Tagliabue E, Colnaghi MI. The 67 kDa laminin receptor as a prognostic factor in human cancer. Breast Cancer Res Treat. 1998; 52: 137-45.
33. Montuori N, Selleri C, Risitano AM, et al. Expression of the 67-kDa laminin receptor in acute myeloid leukemia cells mediates adhesion to laminin and is frequently associated with monocytic differentiation. Clin Cancer Res. 1999; 5: 1465-72.
34. Chen A, Ganor Y, Rahimipour S, et al. The neuropeptides GnRH-II and GnRH-I are produced by human T cell and trigger laminin receptor gene expression, adhesion, chemotaxis and homing to specific organs. Nat Med. 2002; 8: 1421-6.
35. Zuber C, Knackmuss S, Zemora G, et al. Invasion of tumourigenic HT1080 cells is impeded by blocking or downregulating the 37-kDa/67-kDa laminin receptor. J Mol Biol. 2008; 378: 530-9.
36. Scheiman J, Tseng JC, Zheng Y, et al. Multiple functions of the 37/67-kD laminin receptor make it a suitable target for novel cancer gene therapy. Mol Ther. 2010; 18: 63-74.
37. Condorelli G, Vigliotta G, Iavarone C, et al. PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 1998; 17: 3858-66.
38. Gietz D, St Jean A, Woods RA, et al. Improved method for high efficiency transformation of intact yeast cells. Nucleic Acids Res. 1992; 20: 1425.
39. Miller JH, Experiments in molecular genetics, cold spring harbor laboratory. NY: Cold Spring Harbor; 1972.
40. Condorelli G, Trencia A, Vigliotta G, et al. Multiple members of the mitogen-activated protein kinase family are necessary for PED/PEA-15 anti-apoptotic function. J Biol Chem. 2002; 277: 11013-8.
41. Jamieson KV, Hubbard SR, Meruelo D. Structure-guided identification of a laminin binding site on the laminin receptor precursor. J Mol Biol. 2011; 405: 24-32.
42. Douville PJ, Harvey WJ, Carbonetto S. Isolation and partial characterization of high affinity laminin receptors in neural cells. J Biol Chem. 1988; 263: 14964-9.
43. Stallmach A, Schuppan D, Dax J, et al. Identification of laminin binding proteins in cell membranes of a human colon adenocarcinoma cell line. Gut. 1990; 31: 70-6.
44. Botta G, Perruolo G, Libertini S, et al. PED/PEA-15 modulates coxsackievirus-adenovirus receptor expression and adenoviral infectivity via ERK-mediated signals in glioma cells. Hum Gene Ther. 2010; 21: 1067-76.
45. Massia SP, Rao SS, Hubbell JA. Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin. J Biol Chem. 1993; 268: 8053-9.
46. Ramos JW, Hughes PE, Renshaw MW, et al. Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell. 2000; 11: 2863-72.
47. Eblen ST, Slack JK, Weber MJ, et al. Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol. 2002; 22: 6023-33.
48. Reddy KB, Nabha SM, Atanaskova N. Role of MAP kinase in tumour progression and invasion. Cancer Metastasis Rev. 2003; 22: 395-403.
49. Krueger J, Chou FL, Glading A, et al. Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell. 2005; 16: 3552-61.
50. Vaidyanathan H, Opoku-Ansah J, Pastorino S, et al. ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci USA. 2007; 104: 19837-42.
51. Ragno P. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol Life Sci. 2006; 63: 1028-37.
52. Chen FX, Qian YR, Duanm YH, et al. Down-regulation of 67LR reduces the migratory activity of human glioma cells in vitro. Brain Res Bull. 2009; 79: 402-8.
53. Kaneda Y, Kinoshita K, Sato M, et al. The induction of apoptosis in HeLa cells by the loss of LBP-p40. Cell Death Differ. 1998; 5: 20-8.
54. Susantad T, Smith DR. siRNA-mediated silencing of the 37/67-kDa high affinity laminin receptor in Hep3B cells induces apoptosis. Cell Mol Biol Lett. 2008; 13: 452-64.
55. Givant-Horwitz V, Davidson B, Reich R. Laminin-induced signaling in tumour cells: the role of the M(r) 67, 000 laminin receptor. Cancer Res. 2004; 64: 3572-9.
56. Scheiman J, Tseng JC, Zheng Y, et al. Multiple functions of the 37/67-kD laminin receptor make it a suitable target for novel cancer gene therapy. Mol Ther. 2010; 18: 63-74.